| Diagnosis and management of sepsis-induced coagulopathy and disseminated intravascular coagulation |
84 |
| Role of direct oral anticoagulants in the treatment of cancer-associated venous thromboembolism: guidance from the SSC of the ISTH |
73 |
| Inflammation and thrombosis: roles of neutrophils, platelets and endothelial cells and their interactions in thrombus formation during sepsis |
48 |
| Laboratory testing in patients treated with direct oral anticoagulants: a practical guide for clinicians |
45 |
| Laboratory criteria for antiphospholipid syndrome: communication from the SSC of the ISTH |
32 |
| Citrullinated histone H a biomarker of neutrophil extracellular trap formation, predicts the risk of venous thromboembolism in cancer patients |
30 |
| Red blood cells: the forgotten player in hemostasis and thrombosis |
29 |
| Standardization of extracellular vesicle measurements by flow cytometry through vesicle diameter approximation |
27 |
| Derangement of the endothelial glycocalyx in sepsis |
26 |
| Diagnosis and classification of congenital fibrinogen disorders: communication from the SSC of the ISTH |
25 |
| The use of direct oral anticoagulants for primary thromboprophylaxis in ambulatory cancer patients: Guidance from the SSC of the ISTH |
25 |
| The use of platelets in regenerative medicine and proposal for a new classification system: guidance from the SSC of the ISTH |
24 |
| Measuring fibrinolysis: from research to routine diagnostic assays |
24 |
| Tissue factor at the crossroad of coagulation and cell signaling |
23 |
| Low drug levels and thrombotic complications in high-risk atrial fibrillation patients treated with direct oral anticoagulants |
22 |
| Trauma-induced coagulopathy: The past, present, and future |
22 |
| Modified clot waveform analysis to measure plasma coagulation potential in the presence of the anti-factor IXa/factor X bispecific antibody emicizumab |
22 |
| Management of cancer-associated thrombosis in patients with thrombocytopenia: guidance from the SSC of the ISTH |
20 |
| Routine measurements of factor VIII activity and inhibitor titer in the presence of emicizumab utilizing anti-idiotype monoclonal antibodies |
19 |
| An international study on the feasibility of a standardized combined plasma clot turbidity and lysis assay: communication from the SSC of the ISTH |
18 |
| The role of ADAMTS-13 in the coagulopathy of sepsis |
18 |
| High levels of coagulation factors and venous thrombosis risk: strongest association for factor VIII and von Willebrand factor |
17 |
| Flow cytometric analysis of extracellular vesicle subsets in plasma: impact of swarm by particles of non-interest |
16 |
| Direct oral anticoagulant for the prevention of thrombosis in ambulatory patients with cancer: A systematic review and meta-analysis |
16 |
| Drug levels and bleeding complications in atrial fibrillation patients treated with direct oral anticoagulants |
16 |
| Assessment of the analytical performances and sample stability on ST Genesia system using the STG-DrugScreen application |
16 |
| Platelet collagen receptor Glycoprotein VI-dimer recognizes fibrinogen and fibrin through their D-domains, contributing to platelet adhesion and activation during thrombus formation |
16 |
| Anticoagulation of cancer patients with non-valvular atrial fibrillation receiving chemotherapy: Guidance from the SSC of the ISTH |
15 |
| Intracranial hemorrhage with direct oral anticoagulants in patients with brain tumors |
15 |
| Imminent risk of a global shortage of heparin caused by the African Swine Fever afflicting the Chinese pig herd |
15 |
| Hereditary angioedema: the plasma contact system out of control |
15 |
| External validation of the PLASMIC score: a clinical prediction tool for thrombotic thrombocytopenic purpura diagnosis and treatment |
14 |
| McMaster RARE-Bestpractices clinical practice guideline on diagnosis and management of the catastrophic antiphospholipid syndrome |
14 |
| Laboratory assay measurement of modified clotting factor concentrates: a review of the literature and recommendations for practice |
14 |
| The sensitivity and specificity of platelet autoantibody testing in immune thrombocytopenia: a systematic review and meta-analysis of a diagnostic test |
14 |
| Direct oral anticoagulants in patients with venous thromboembolism and thrombophilia: a systematic review and meta-analysis |
14 |
| Thromboelastography-guided therapy improves patient blood management and certain clinical outcomes in elective cardiac and liver surgery and emergency resuscitation: A systematic review and analysis |
14 |
| Cerebral venous sinus thrombosis |
14 |
| An open conformation of ADAMTS-13 is a hallmark of acute acquired thrombotic thrombocytopenic purpura |
14 |
| A randomized trial of safety, pharmacokinetics and pharmacodynamics of concizumab in people with hemophilia A |
14 |
| Acquired coagulopathy in patients with left ventricular assist devices |
14 |
| Curated disease-causing genes for bleeding, thrombotic, and platelet disorders: Communication from the SSC of the ISTH |
13 |
| Regulation of plasminogen activation on cell surfaces and fibrin |
13 |
| Flavin monooxygenase the host hepatic enzyme in the metaorganismal trimethylamine N-oxide-generating pathway, modulates platelet responsiveness and thrombosis risk |
13 |
| Leukocytes as a reservoir of circulating oncogenic DNA and regulatory targets of tumor-derived extracellular vesicles |
12 |
| Scientific and Standardization Committee Communication: Guidance document on the periprocedural management of patients on chronic oral anticoagulant therapy: Recommendations for standardized reporting of procedural/surgical bleed risk and patient-specific thromboembolic risk |
12 |
| Use of direct oral anticoagulants in antiphospholipid syndrome |
12 |
| Staphylococcus aureus, master manipulator of the human hemostatic system |
11 |
| Hollow organosilica beads as reference particles for optical detection of extracellular vesicles |
11 |
| Genetic regulation of plasma von Willebrand factor levels in health and disease |
11 |
